Showing results (11-20 of 156) with videos related to

Sort By:
Pageof 16
Nature Reviews. Endocrinology|January 29, 2014
Immune modulation in humans: implications for type 1 diabetes mellitusBart O Roep, Timothy I M Tree
F1000 Biology Reports|November 1, 2012
Can we vaccinate against Type 1 diabetes?Mark Peakman
Novartis Foundation Symposium|February 11, 2009
CD8 and cytotoxic T cells in type 1 diabetesMark Peakman
Cold Spring Harbor Perspectives in Medicine|September 16, 2024
Autoantigen-Specific Immunotherapies for the Prevention and Treatment of Type 1 DiabetesMark Peakman, Pere Santamaria
Current Opinion in Organ Transplantation|December 11, 2012
Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantationJames L Reading, Shereen Sabbah, Sarah Busch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 31, 2012
Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell functionGarima Garg, Jennifer R Tyler, Jennie H M Yang, et al.
Diabetes/Metabolism Research and Reviews|December 4, 2003
Enteroviruses and type 1 diabetesRuben Varela-Calvino, Mark Peakman
Nature Reviews. Immunology|January 26, 2010
Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetesBart O Roep, Mark Peakman
Frontiers in Immunology|March 16, 2018
Peptide Immunotherapy for Type 1 Diabetes-Clinical AdvancesEmma L Smith, Mark Peakman
Current Opinion in Immunology|November 5, 2011
Diabetogenic T lymphocytes in human Type 1 diabetesBart O Roep, Mark Peakman
Pageof 16